K Dobashi Selected Research

K Dobashi Research Topics

Disease

5	Asthma (Bronchial Asthma) 04/2011 - 06/2000
2	Idiopathic Pulmonary Fibrosis 07/2014 - 04/2010
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 07/2014 - 07/2008
2	Fibrosis (Cirrhosis) 01/2014 - 01/2001
2	Inflammation (Inflammations) 02/2012 - 06/2000
2	Asbestosis 01/2010 - 07/2008
2	Lung Neoplasms (Lung Cancer) 07/2008 - 11/2000
1	Lung Diseases (Lung Disease) 02/2013
1	Bronchiolitis 01/2010
1	Sinusitis 01/2010
1	Neoplasms (Cancer) 07/2008
1	Churg-Strauss Syndrome (Allergic Angiitis) 01/2008
1	Hypoxia (Hypoxemia) 01/2008
1	Vasculitis (Vasculitides) 01/2008
1	Migraine Disorders (Migraine) 07/2002
1	Hypercapnia 07/2002
1	Endometrial Neoplasms (Endometrial Cancer) 12/2001
1	Gastroesophageal Reflux (GERD) 10/2001
1	Allergic Rhinitis 08/2001
1	Body Weight (Weight, Body) 04/2001
1	Obesity 04/2001
1	Respiratory Insufficiency (Respiratory Failure) 10/2000
1	Cardiomegaly (Heart Hypertrophy) 10/2000
1	Chronic Obstructive Pulmonary Disease (COPD) 06/2000
1	Diabetic Nephropathies (Diabetic Nephropathy) 05/2000
1	Pleural Effusion (Pleural Effusions) 05/2000
1	Exanthema (Rash) 04/2000
1	Blister (Bulla) 04/2000
1	Reperfusion Injury 02/2000
1	Ischemia 02/2000
1	Bacterial Pneumonia 01/2000
1	Infections 01/2000
1	Pulmonary Tuberculosis 01/2000
1	Phaeohyphomycosis 01/2000

Drug/Important Bio-Agent (IBA)

3	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2012 - 01/2008
3	Proteins (Proteins, Gene)FDA Link 04/2001 - 02/2000
2	Pharmaceutical PreparationsIBA 07/2014 - 07/2002
2	Protons (Proton)IBA 02/2013 - 07/2008
2	AsbestosIBA 01/2010 - 07/2008
2	Oxygen (Dioxygen)IBA 01/2008 - 10/2000
1	pirfenidoneIBA 07/2014
1	Protein Isoforms (Isoforms)IBA 01/2014
1	Bronchodilator Agents (Bronchodilators)IBA 04/2011
1	anti-IgE antibodiesIBA 04/2011
1	CytokinesIBA 04/2011
1	Anti-Allergic Agents (Antiallergic Agents)IBA 04/2011
1	Immunoglobulin E (IgE)IBA 04/2011
1	Interleukin-16 (Interleukin 16)IBA 04/2011
1	Omalizumab (Xolair)FDA Link 04/2011
1	Monoclonal AntibodiesIBA 04/2011
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 04/2010
1	Chemokine CXCL12IBA 04/2010
1	Carcinoembryonic AntigenIBA 01/2010
1	SteroidsIBA 01/2010
1	8-epi-prostaglandin F2alphaIBA 01/2008
1	ThrombomodulinIBA 01/2008
1	AcidsIBA 01/2008
1	Sumatriptan (Imigran)FDA LinkGeneric 07/2002
1	Estrogens (Estrogen)FDA Link 12/2001
1	Progestins (Progestagens)IBA 12/2001
1	Chemotactic FactorsIBA 08/2001
1	Glutathione PeroxidaseIBA 04/2001
1	Blood Glucose (Blood Sugar)IBA 04/2001
1	Troglitazone (Rezulin)FDA Link 04/2001
1	PeroxidasesIBA 04/2001
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2001
1	Glutathione (Reduced Glutathione)IBA 04/2001
1	Y 27632IBA 01/2001
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2001
1	Monomeric GTP-Binding ProteinsIBA 01/2001
1	Complementary DNA (cDNA)IBA 11/2000
1	Theophylline (Theon)FDA LinkGeneric 06/2000
1	Lipid PeroxidesIBA 06/2000
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 06/2000
1	AlbuminsIBA 05/2000
1	CreatinineIBA 05/2000
1	Hemoglobins (Hemoglobin)IBA 05/2000
1	Tuberculin (PPD)IBA 04/2000
1	CatalaseIBA 02/2000
1	Messenger RNA (mRNA)IBA 02/2000
1	AntioxidantsIBA 02/2000
1	EnzymesIBA 02/2000
1	Interleukin-10 (Interleukin 10)IBA 01/2000
1	Antitubercular AgentsIBA 01/2000
1	Flucytosine (Ancobon)FDA Link 01/2000
1	Interleukin-12 (IL 12)IBA 01/2000

Therapy/Procedure

4	Therapeutics 04/2011 - 11/2000
1	Estrogen Replacement Therapy 12/2001
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 12/2001
1	Drug Therapy (Chemotherapy) 05/2000
1	X-Ray Film 05/2000